Patent · US Active

Biocatalysts for ezetimibe synthesis

US12110512B2 · kind B2 · utility

0Cited by
38References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 17, 2021
Grant dateOct 8, 2024
Priority date
Expiry dateSep 22, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12P17/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates to non-naturally occurring polypeptides useful for preparing Ezetimibe, polynucleotides encoding the polypeptides, and methods of using the polypeptides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.